These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8586466)

  • 21. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 from basic research to clinical applications.
    Tominaga O; Hamelin R; Remvikos Y; Salmon RJ; Thomas G
    Crit Rev Oncog; 1992; 3(3):257-82. PubMed ID: 1616957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
    Satyamoorthy K; Chehab NH; Waterman MJ; Lien MC; El-Deiry WS; Herlyn M; Halazonetis TD
    Cell Growth Differ; 2000 Sep; 11(9):467-74. PubMed ID: 11007451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
    Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
    Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC
    Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
    Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
    Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions.
    Inga A; Nahari D; Velasco-Miguel S; Friedberg EC; Resnick MA
    Oncogene; 2002 Aug; 21(37):5704-15. PubMed ID: 12173040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene.
    Kikuchi T; Rempel SA; Rutz HP; de Tribolet N; Mulligan L; Cavenee WK; Jothy S; Leduy L; Van Meir EG
    Cancer Res; 1993 Mar; 53(5):957-61. PubMed ID: 8439970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of the p53 gene in gliomas from Malay patients.
    Jafri A; Aziz MY; Ros S; Nizam I
    Med J Malaysia; 2003 Jun; 58(2):236-42. PubMed ID: 14569744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family.
    Lomax ME; Barnes DM; Gilchrist R; Picksley SM; Varley JM; Camplejohn RS
    Oncogene; 1997 Apr; 14(15):1869-74. PubMed ID: 9150393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.
    Avigad S; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R
    Oncogene; 1997 Apr; 14(13):1541-5. PubMed ID: 9129144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathways in the formation of gliomas.
    von Deimling A; Louis DN; Wiestler OD
    Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.
    Batista LF; Roos WP; Kaina B; Menck CF
    Mol Cancer Res; 2009 Feb; 7(2):237-46. PubMed ID: 19208740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.